Market Intelligence chevron_right Pharma & Healthcare chevron_right Nucleic Acid-Based Multiplex Assays
Global Report 2021

Global Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2023-2027

calendar_todayPublished: Dec 2021 descriptionPages: 108 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Reagents & Consumables
        1.2.3 Instruments & Accessories
        1.2.4 Software & Services
    1.3 Market by Application
        1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Companion Diagnostics
        1.3.3 Research & Development
        1.3.4 Clinical Diagnostics
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2016-2027)
    2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions
        2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2016-2021)
        2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027)
    2.3 Nucleic Acid-Based Multiplex Assays Industry Dynamic
        2.3.1 Nucleic Acid-Based Multiplex Assays Market Trends
        2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers
        2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges
        2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue
        3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2016-2021)
        3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2016-2021)
    3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue
    3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio
        3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2020
    3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served
    3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
    3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type
    4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2016-2021)
    4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027)

5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application
    5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2016-2021)
    5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
    6.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type
        6.2.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
        6.2.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
        6.2.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
    6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application
        6.3.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
        6.3.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
        6.3.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
    6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country
        6.4.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
        6.4.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
    7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type
        7.2.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
        7.2.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
        7.2.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
    7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application
        7.3.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
        7.3.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
        7.3.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
    7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country
        7.4.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
        7.4.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
    8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type
        8.2.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
    8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application
        8.3.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
    8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region
        8.4.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
    9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type
        9.2.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
        9.2.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
        9.2.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
    9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application
        9.3.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
        9.3.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
        9.3.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
    9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country
        9.4.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
        9.4.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
    10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type
        10.2.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
    10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application
        10.3.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
    10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country
        10.4.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Luminex
        11.1.1 Luminex Company Details
        11.1.2 Luminex Business Overview
        11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction
        11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.1.5 Luminex Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Details
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction
        11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 Illumina
        11.3.1 Illumina Company Details
        11.3.2 Illumina Business Overview
        11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction
        11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.3.5 Illumina Recent Development
    11.4 Bio-Rad Lab
        11.4.1 Bio-Rad Lab Company Details
        11.4.2 Bio-Rad Lab Business Overview
        11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction
        11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.4.5 Bio-Rad Lab Recent Development
    11.5 QIAGEN
        11.5.1 QIAGEN Company Details
        11.5.2 QIAGEN Business Overview
        11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction
        11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.5.5 QIAGEN Recent Development
    11.6 BD
        11.6.1 BD Company Details
        11.6.2 BD Business Overview
        11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction
        11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.6.5 BD Recent Development
    11.7 Abcam
        11.7.1 Abcam Company Details
        11.7.2 Abcam Business Overview
        11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction
        11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.7.5 Abcam Recent Development
    11.8 Seegene
        11.8.1 Seegene Company Details
        11.8.2 Seegene Business Overview
        11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction
        11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.8.5 Seegene Recent Development
    11.9 Meso Scale Diagnostics
        11.9.1 Meso Scale Diagnostics Company Details
        11.9.2 Meso Scale Diagnostics Business Overview
        11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction
        11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.9.5 Meso Scale Diagnostics Recent Development
    11.10 Randox Laboratories
        11.10.1 Randox Laboratories Company Details
        11.10.2 Randox Laboratories Business Overview
        11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction
        11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
        11.10.5 Randox Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Reagents & Consumables
    Table 3. Key Players of Instruments & Accessories
    Table 4. Key Players of Software & Services
    Table 5. Global Nucleic Acid-Based Multiplex Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Nucleic Acid-Based Multiplex Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Nucleic Acid-Based Multiplex Assays Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Nucleic Acid-Based Multiplex Assays Market Share by Regions (2016-2021)
    Table 9. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Nucleic Acid-Based Multiplex Assays Market Share by Regions (2022-2027)
    Table 11. Nucleic Acid-Based Multiplex Assays Market Trends
    Table 12. Nucleic Acid-Based Multiplex Assays Market Drivers
    Table 13. Nucleic Acid-Based Multiplex Assays Market Challenges
    Table 14. Nucleic Acid-Based Multiplex Assays Market Restraints
    Table 15. Global Nucleic Acid-Based Multiplex Assays Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Nucleic Acid-Based Multiplex Assays Market Share by Players (2016-2021)
    Table 17. Global Top Nucleic Acid-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-Based Multiplex Assays as of 2020)
    Table 18. Ranking of Global Top Nucleic Acid-Based Multiplex Assays Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Nucleic Acid-Based Multiplex Assays Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
    Table 22. Date of Enter into Nucleic Acid-Based Multiplex Assays Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2016-2021)
    Table 26. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Nucleic Acid-Based Multiplex Assays Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2016-2021)
    Table 30. Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Luminex Company Details
    Table 63. Luminex Business Overview
    Table 64. Luminex Nucleic Acid-Based Multiplex Assays Product
    Table 65. Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 66. Luminex Recent Development
    Table 67. Thermo Fisher Scientific Company Details
    Table 68. Thermo Fisher Scientific Business Overview
    Table 69. Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Product
    Table 70. Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 71. Thermo Fisher Scientific Recent Development
    Table 72. Illumina Company Details
    Table 73. Illumina Business Overview
    Table 74. Illumina Nucleic Acid-Based Multiplex Assays Product
    Table 75. Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 76. Illumina Recent Development
    Table 77. Bio-Rad Lab Company Details
    Table 78. Bio-Rad Lab Business Overview
    Table 79. Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Product
    Table 80. Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 81. Bio-Rad Lab Recent Development
    Table 82. QIAGEN Company Details
    Table 83. QIAGEN Business Overview
    Table 84. QIAGEN Nucleic Acid-Based Multiplex Assays Product
    Table 85. QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 86. QIAGEN Recent Development
    Table 87. BD Company Details
    Table 88. BD Business Overview
    Table 89. BD Nucleic Acid-Based Multiplex Assays Product
    Table 90. BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 91. BD Recent Development
    Table 92. Abcam Company Details
    Table 93. Abcam Business Overview
    Table 94. Abcam Nucleic Acid-Based Multiplex Assays Product
    Table 95. Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 96. Abcam Recent Development
    Table 97. Seegene Company Details
    Table 98. Seegene Business Overview
    Table 99. Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 100. Seegene Recent Development
    Table 101. Meso Scale Diagnostics Company Details
    Table 102. Meso Scale Diagnostics Business Overview
    Table 103. Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Product
    Table 104. Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 105. Meso Scale Diagnostics Recent Development
    Table 106. Randox Laboratories Company Details
    Table 107. Randox Laboratories Business Overview
    Table 108. Randox Laboratories Nucleic Acid-Based Multiplex Assays Product
    Table 109. Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) & (US$ Million)
    Table 110. Randox Laboratories Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nucleic Acid-Based Multiplex Assays Market Share by Type: 2020 VS 2027
    Figure 2. Reagents & Consumables Features
    Figure 3. Instruments & Accessories Features
    Figure 4. Software & Services Features
    Figure 5. Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2020 VS 2027
    Figure 6. Companion Diagnostics Case Studies
    Figure 7. Research & Development Case Studies
    Figure 8. Clinical Diagnostics Case Studies
    Figure 9. Nucleic Acid-Based Multiplex Assays Report Years Considered
    Figure 10. Global Nucleic Acid-Based Multiplex Assays Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Nucleic Acid-Based Multiplex Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Nucleic Acid-Based Multiplex Assays Market Share by Regions: 2020 VS 2027
    Figure 13. Global Nucleic Acid-Based Multiplex Assays Market Share by Regions (2022-2027)
    Figure 14. Global Nucleic Acid-Based Multiplex Assays Market Share by Players in 2020
    Figure 15. Global Top Nucleic Acid-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid-Based Multiplex Assays as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Nucleic Acid-Based Multiplex Assays Revenue in 2020
    Figure 17. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2016-2021)
    Figure 18. Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Type (2022-2027)
    Figure 19. North America Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Nucleic Acid-Based Multiplex Assays Market Share by Type (2016-2027)
    Figure 21. North America Nucleic Acid-Based Multiplex Assays Market Share by Application (2016-2027)
    Figure 22. North America Nucleic Acid-Based Multiplex Assays Market Share by Country (2016-2027)
    Figure 23. United States Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Nucleic Acid-Based Multiplex Assays Market Share by Type (2016-2027)
    Figure 27. Europe Nucleic Acid-Based Multiplex Assays Market Share by Application (2016-2027)
    Figure 28. Europe Nucleic Acid-Based Multiplex Assays Market Share by Country (2016-2027)
    Figure 29. Germany Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Share by Region (2016-2027)
    Figure 39. China Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Nucleic Acid-Based Multiplex Assays Market Share by Type (2016-2027)
    Figure 47. Latin America Nucleic Acid-Based Multiplex Assays Market Share by Application (2016-2027)
    Figure 48. Latin America Nucleic Acid-Based Multiplex Assays Market Share by Country (2016-2027)
    Figure 49. Mexico Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Share by Country (2016-2027)
    Figure 55. Turkey Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Nucleic Acid-Based Multiplex Assays Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Luminex Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 60. Illumina Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 61. Bio-Rad Lab Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 62. QIAGEN Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 63. BD Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 64. Abcam Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 65. Seegene Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 66. Meso Scale Diagnostics Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 67. Randox Laboratories Revenue Growth Rate in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories

Frequently Asked Questions

What is the USP of the report? expand_more
Nucleic Acid-Based Multiplex Assays report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Nucleic Acid-Based Multiplex Assays report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Nucleic Acid-Based Multiplex Assays report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.